Our Founders
Peter Feldman, Co-Founder/CEO
Co-founder/CEO of Medical Databanks (CRO), United Health Registries (CRO), and Petrah (Data Analytics). Previous Rapporteur to World Health Organization’s Global Observatory on Cell, Tissue and Organ Transplantation. Recipient of the Norman Bethune Award from the Canadian Medical Association.
Deborah Cahan, Co-Founder/Executive VP
Former Director of Medical Databanks (CRO) and Petrah (Data Analytics).
Medical Team
Jaime Guevara-Aguirre, MD
Professor at the University of Florida College of Medicine and Professor of Diabetes and Endocrinology at Universidad San Francisco de Quito. Founded the Institute of Endocrinology, Metabolism, and Reproduction (IEMYR) in Quito, Ecuador. Acknowledged research pioneer in disease treatment relating to human growth mechanisms, cell metabolism and stem cell differentiation. Former scientific advisor to Generex, Tercica, now Ipsen Biopharmaceuticals, and Diagnostic Systems Laboratories. Author of multiple peer-reviewed publications. To view Dr. Guevara-Aguirre’s publications, click here.
Kurt Stenn, MD, MA, MBA
30 years of expertise studying hair. Distinguished academic career as Professor of Pathology and Dermatology at Yale University School of Medicine (20 years) and Director of Skin Biology at Johnson & Johnson (10 years). Previous faculty member at University of Pennsylvania Medical School, Drexel University, and Georgia Institute of Technology. Lectured extensively on the biology of the hair follicle, and written over 200 peer review scientific publications. To view Dr. Stenn’s publications, click here.
Scientific Team
Dennis M. Brown, PhD
Founded Matrix Pharmaceutical, DelMar Pharmaceuticals and ChemGenex Therapeutics. Currently, Executive Chairman of Cell Source, Inc, Chairman of Mountain View Pharmaceuticals, Inc. President of Valent Technologies LLC and Chief Scientific Officer of DelMar Pharmaceuticals. Previous advisor to EGB Ventures LLC. Assistant Professor at Harvard Medical School and Research Associate at Stanford University School of Medicine.
Klaus Fiebig, PhD
27 years of experience in molecular research, drug discovery, investment and commercialization. Former Chief Science Officer & VP Research Programs at Ontario Genomics Institute responsible for $800m of research investments. PhD from UCSF with post-doctoral fellowships at UCSF, Oxford and Yale.
Charles Piwko, MSc, PharmD, PhD
25 years of research expertise in multiple therapeutic areas and all phases of drug development including: reimbursement and pricing evaluations for global pharma, biotech, and consumer health and payors. Therapeutic Technology Assessment Expert. PharmD, PhD (Pharmacology), MSc (Health Economics).
Management Team
Gerry Goldberg, CPA, Finance
40 years of experience in public company auditing in USA and Canada. Experience as CEO, Chairman, independent director and member of audit committees of public companies. Former Senior Partner and Head of Audit division at Schwartz Levitsky Feldman LLP and President of SLF Capital Markets Inc.
Martin Mezulis, Operations
30 years experience in Supply Chain and IT Transformation. Former ERP Program Manager PepsiCo International. Previous experience at SAP, Fujitsu and Molson Breweries.
Corporate Advisory Team
Bruce Bent, CPA
Director of public and private companies. CFO of Matthews Southwest in Dallas, Texas. Responsibilities include: oversight of $200 million of real estate, joint venture interest in an additional $300 million of real estate and for excess of $2 billion of construction and new venture investments.
Manfred Leventhal, CPA
Director of public and private companies. History of investing and taking companies public. Former CFO and COO of Tau Capital Corp. Previous Senior Principal at the head office of KPMG.